knowledge -WSS

knowledge

author：explore 2025-09-30 18:20:50 - browse：725

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： It's been 20 years since Dolly the sheep. Where's my clone?

explore

WSS

Drug for rare kidney disease narrowly misses mark in clinical trial

How Vertex's cystic fibrosis drug is changing patients' lives

EpiPen alternative approval delay highlights citizen petition issue

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Empower primary care with adequate payments and technology

STAT Virtual Event: Putting AI to the Test

leisure time

knowledge

entertainment

How to save PrEP access — and even expand it

What Congress can do to address the rural doctor shortage

Duchenne breakthrough therapy leaves behind pioneering families

It's been 20 years since Dolly the sheep. Where's my clone?

Hollywood unions extend contract negotiations for actors

Brain technologies pose threats that are all too real, experts warn

Medical leaders decry Supreme Court decision on affirmative action

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Duchenne breakthrough therapy leaves behind pioneering families

Biotech stock slump in 2023: awaiting the turnaround

hotspot

Lasker Awards 2023: Winners in biomedical research

Crowdfunding for medical bills sidesteps core problem, author says

STAT Virtual Event: Putting AI to the Test

Empower primary care with adequate payments and technology

As billionaires fund anti

How a small hospital in rural Puerto Rico survived Hurricane Maria

explore

entertainment

hotspot

focus